Navigation Links
Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares
Date:11/11/2013

st ratings and price targets - is available to download free of charge at:

[http://www.analystscorner.com/r/full_research_report/4c0d_CHE]

--

Foundation Medicine, Inc. Research Report

On November 6, 2013, Foundation Medicine, Inc. (Foundation Medicine) reported its Q3 2013 financial results. During the quarter, the Company's revenues totaled $8.2 million, up 170.3% YoY. The Company informed that more than half of its quarterly revenues came from clinical testing. Q3 2013 net loss was $12.5 million, or $3.51 loss per basic and diluted share, compared with a net loss of $5.6 million, or $2.39 per basic and diluted share, in Q3 2012. "Results in the third quarter demonstrate the growing enthusiasm in the marketplace for our fully informative genomic profile for use across all solid tumors," said Michael Pellini, M.D., President and CEO of Foundation Medicine. "We are very encouraged by the commercial traction as the utility of FoundationOne and the information it delivers garners growing recognition among oncologists, pathologists and pharmaceutical companies. In addition, the number of scientific publications generated using our molecular information platform during the quarter continues to underscore its clinical utility and value in the care of patients with cancer." The Full Research Report on Foundation Medicine, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

[http://www.analystscorner.com/r/full_research_report/d9a0_FMI]

--

Antares Pharma, Inc. Research Report

On November 6, 2013, Antares Pharma, Inc. (Antares) reported its Q3 2013 financial results. The Company's revenues totaled $5.5 million, down 3.1% YoY during the quarter. Q3 2013 net loss was $0.05 pe
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Preliminary Phase 2 Data of Ocera Therapeutics OCR-002 for the Treatment of Liver Cirrhosis and Upper GI Bleeding Show Potent Ammonia Reduction
2. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
3. Pro-Dex Provides Insight Into Fiscal 2013 Operating Plan And Preliminary Results For Fiscal 2012
4. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
5. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
6. CareFusion To Report Preliminary Fiscal 2013 First Quarter Results On Nov. 8
7. Cardinal Health Announces Preliminary Shareholder Voting Results at 2012 Annual Meeting
8. CareFusion Reports Preliminary First Quarter Fiscal 2013 Results
9. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
11. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds ... to its store . (Photo: ... of population, consumption upgrade and policy support, ... seen rapid development over the years, with total ... 2006 to 9.85 billion yuan in 2012. ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, ... and contracting company, awarded several new IT value-added ... to provide hospital organizations with IT goods and ... and service agreements, as well as value-added services ... support. New Novation agreements were ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), ... distributor of highly sophisticated agro-breeding solutions for plant breeders ... the Company,s board of directors appointed chemistry and pharmaceutical ... new member of the board. From 1975 ... Pharmaceutical Industries Ltd (NYSE: TEVA ) and ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... International (OTC Bulletin Board: SNDZ ) said ... for glaucoma and ocular hypertension, is making its mark ... Trading Co. Ltd. (BVW), in 2007, the PNT treatment ... gaining regulatory approval by China,s Federal Drug Administration earlier ...
... and eCardio Diagnostics, one of the leading providers ... of mobile technology with cardiac care to provide ... is providing eCardio with machine-to-machine (M2M) ... remote monitoring of cardiac patients. eCardio,s monitoring solution ...
Cached Medicine Technology:Sunridge Advances its PNT Glaucoma Treatment Throughout China 2AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 2AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 3
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... , , , ... AMLN ) today reported financial results for the quarter ended June 30, ... ended June 30, 2009, which includes net product sales of $197.5 million. ... sales force reduction in the second quarter, was $51.0 million, or $0.36 ...
... , , , , ... the second quarter of fiscal 2009 on Thursday, August 6, 2009. , ... hosted by management at 11 a.m. ET following distribution of the earnings release. ... , in the News Room on the day of the earnings announcement. ...
... ... ... 1-800-731-5774, ... PRINCETON, NJ, July 21 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. invites analysts and investors to participate in a briefing on ...
... three cases of likely HIV transmission to infants via pre-chewed food ... - chewing food; also a need for more ... Researchers have uncovered the first cases in which HIV almost ... The source of HIV in the pre-chewed food was most likely the infected ...
... , MEQUON, Wis., July 21 Wonderbox ... its clients to benefit from continued advances in technology and ... Management Module designed for managed care benefit administration and case ... tools for scheduling, managing, and monitoring day-to-day care tasks and ...
... diagnose disease early, study shows, , TUESDAY, July 21 ... may accurately identify the people with mild cognitive impairment ... new study finds. , Changes in the chemistry of ... Alzheimer,s disease. If and when treatments are available for ...
Cached Medicine News:Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 2Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 3Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 4Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 5Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 6Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 7Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 8Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 9Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 10Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 11Health News:Amylin Pharmaceuticals Reports Second Quarter Financial Results 12Health News:US Oncology to Report 2009 Second Quarter Operating Results 2Health News:Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results 2Health News:Pre-chewed Food Could Transmit HIV 2Health News:Pre-chewed Food Could Transmit HIV 3Health News:Pre-chewed Food Could Transmit HIV 4Health News:Wonderbox Technologies(R) Releases Version 4.5 of the Enterprise System 2Health News:Biomarkers May Predict Alzheimer's 2Health News:Biomarkers May Predict Alzheimer's 3
The STAAR ELASTIMIDE™ lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
Foldable Silicone Multi-piece Lens....
... The PhacoFlexII SI30NB is foldable ... to it's patients. It is ... The SI30NB is indicated for ... correction of aphakia in adults ...
Liberty Three Piece PMMA Lens with UV Absorber....
Medicine Products: